Detalhe da pesquisa
1.
Accrual Quality Improvement Program for clinical trials.
Clin Trials
; : 17407745241243027, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38591816
2.
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.
Prostate
; 81(1): 41-49, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095939
3.
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.
J Oncol Pharm Pract
; 21(2): 128-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24642450
4.
Prostate cancer prevention: agent development strategies.
Recent Results Cancer Res
; 202: 121-31, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24531786
5.
Prostate cancer prevention: strategies for agent development.
Curr Opin Oncol
; 25(3): 242-51, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23518594
6.
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Int J Gynaecol Obstet
; 163(3): 862-867, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431689
7.
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
Eur Urol Focus
; 9(3): 447-454, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517408
8.
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs.
Cancer Prev Res (Phila)
; 15(5): 279-284, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35502553
9.
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.
Cancer Prev Res (Phila)
; 15(11): 721-726, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001346
10.
A Microfluidic Device for Automated High Throughput Detection of Ice Nucleation of Snomax®.
Micromachines (Basel)
; 12(3)2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799595
11.
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.
Cancer Prev Res (Phila)
; 12(12): 903-912, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484659
12.
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
Cancer Prev Res (Phila)
; 10(5): 298-307, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28325826
13.
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.
Am J Clin Exp Urol
; 4(2): 17-27, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766277
14.
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.
Eur J Cancer Prev
; 25(4): 312-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26313229
15.
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Cancer Prev Res (Phila)
; 5(4): 621-30, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22293631
16.
BCAN Think Tank session 3: Prevention of bladder cancer.
Urol Oncol
; 28(3): 338-42, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439034
17.
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
J Urol
; 171(2 Pt 2): S68-74; discussion S75, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14713758